MINDCURE to Present at the Benzinga Healthcare Small Cap Conference
VANCOUVER,BC, September28, 2021 /CNW/ – MindCure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH)(“MINDCURE” or the “Company”), a leader inadvanced proprietary technology and research in psychedelics, today announcedthat Kelsey Ramsden, President & CEO of MINDCURE, will present at the BenzingaHealthcare Small Cap Conference, which is being held virtually on September29-30, 2021. Investors can register for the conference here.
In addition, Ms. Ramsden will participate inone-on-one investor meetings during the conference. To schedule a one-on-onemeeting, please contact KCSA Strategic Communications at MindCure@kcsa.com.
Benzinga Healthcare Small Cap Conference Presentation
Date: Wednesday,September 29, 2021
Time: 4:00 pm ET
Speaker: Kelsey Ramsden, President & CEO of MINDCURE
Link: Healthcare:September 29-30 – Benzinga Small Cap Conference
In other news, the Company also announces ithas granted a total of 10,000 stock options to certain employees pursuant tothe terms the Company’s long term incentive plan (“Plan”). The stock optionsare exercisable at a price of $0.34 per share, and are subject to the terms ofthe Plan. The Company further announces it has issued 59,296 common shares to aconsultant at an agreed-upon price of $0.38 per share.
About Mind Cure Health Inc.
MINDCURE is a life sciencescompany focused on innovating and commercializing new ways to promote healingand improve mental health. The Company is developing digital therapeuticstechnology and researching psychedelic compounds to support access to safe, evidence-basedpsychedelic-assisted therapies globally. Learn more at mindcure.com, and follow us on LinkedIn, Facebook, Twitter, and Instagram.
On Behalf of the Board ofDirectors
KelseyRamsden, President & CEO
Phone:1-888-593-8995
Forward-Looking Information
Certaininformation presented in this news release may constitute “forward-lookinginformation” within the meaning of applicable securities laws regardingMINDCURE and its business. Forward-looking information generally can beidentified by the use of terms and phrases such as “anticipate”,”believe”, “could”, “estimate”,”expect”, “feel”, “intend”, “may”,”plan”, “predict”, “project”, “subjectto”, “will”, “would”, and similar terms and phrases.
Forward-lookinginformation is based on a number of key expectations and assumptions made bymanagement of MINDCURE, including, without limitation: the COVID-19 pandemicimpact on the Canadian economy and MINDCURE’s business, and the extent andduration of such impact; no change to laws or regulations that negativelyaffect MINDCURE’s business; there will be a demand for MINDCURE’s products inthe future; no unanticipated expenses or costs arise; MINDCURE will be able tocontinue to identify products that make them ideal candidates for providingsolutions for treating mental health; and that MINDCURE will advance wellnessworldwide.
Forward-lookinginformation is provided for the purpose of presenting information aboutmanagement’s current expectations and plans relating to the future and readersare cautioned that such statements may not be appropriate for other purposes.Forward-looking information inherently entails known and unknown risks anduncertainties about the future and actual results, and involves significantrisks and uncertainties and should not be read as a guarantee of futureperformance or results as actual results may differ materially from thoseexpressed or implied in such forward-looking information. Although MINDCURE hasattempted to identify important factors that could cause actual results,performance or achievements to differ materially from those described in forward-lookinginformation presented, there may be other factors that cause results,performance or achievements to differ from those anticipated, estimated orintended. Accordingly, readers should not place undue reliance on anyforward-looking statements as no forward-looking information can be guaranteed.
Except asrequired by applicable securities laws, forward-looking statements speak onlyas of the date on which they are made and MINDCURE does not undertake anyobligation to publicly update or revise any forward-looking information,whether as a result of new information, future events, or otherwise.
SOURCE Mind Cure Health Inc.
For further information:
MINDCURE Investor Relations
investors@mindcure.com
1-888-593-8995
Media Inquiries
Annie Graf / Kristin Cwalinski
KCSA Strategic Communications
mindcure@kcsa.com